Showing results (791-800 of 835) with videos related to
Sort By:
Pageof 84
Journal for Immunotherapy of Cancer|June 19, 2026
Differential cytokine architecture in patients treated with CART19 versus CART22Caroline Diorio, Rawan Shraim, Anusha Thadi, et al.Nature Biomedical Engineering|August 25, 2025
Directed evolution-based discovery of ligands for in vivo restimulation of chimeric antigen receptor T cellsTomasz M Grzywa, Alexandra Neeser, Ranjani Ramasubramanian, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19Caroline Diorio, Rawan Shraim, Regina Myers, et al.BMJ Open|November 22, 2023
Stratification of risk for emergent intracranial abnormalities in children with headaches: a Pediatric Emergency Care Applied Research Network (PECARN) study protocolDaniel S Tsze, Nathan Kuppermann, T Charles Casper, et al.Substance Abuse|July 8, 2021
Adolescent alcohol use predicts cannabis use over a three year follow-up periodJames G Linakis, Sarah A Thomas, Julie R Bromberg, et al.Nature Communications|April 23, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignanciesPablo Domizi, Jolanda Sarno, Astraea Jager, et al.Cancer Discovery|April 15, 2016
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic LeukemiaDavid T Teachey, Simon F Lacey, Pamela A Shaw, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2021
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALLRegina M Myers, Agne Taraseviciute, Seth M Steinberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2026
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALLStephan A Grupp, Shannon L Maude, Susana Rives, et al.Journal for Immunotherapy of Cancer|August 6, 2021
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemiaJohn E Levine, Stephan A Grupp, Michael A Pulsipher, et al.Pageof 84